Latest News

  • Pangaea Launches Next-Gen Platform, EpiSign’s METRIC Released, Biodesix, Bio-Rad Laboratories Partner Up

    Diagnostics World | Pangaea launches its next-generation platform; EpiSign launches its Methylation-based Episignature Testing and Reference-based Interpretation & Classification (METRIC); Biodesix signs an expanded partnership agreement with Bio-Rad Laboratories; and more.

    Oct 29, 2025
  • Follow the Money: Obesity Weight Loss Drug, Trojan Horse Approach for Diseases, More

    Diagnostics World | Kailera Therapeutics advances their obesity portfolio; Trogenix combines cancer cell killing and immune stimulation, delivered via a Trojan Horse approach that reawakens the immune system; and more.

    Oct 28, 2025
  • New AI Tool Addresses Data Accuracy and Fairness

    Diagnostics World | Modern healthcare algorithms are trained with large volumes of data and can recognize patterns and correlate them with outcomes. However, there is still the issue of bias against underrepresented groups, even though these algorithms are trained using diverse populations. Researchers from the Icahn School of Medicine at Mount Sinai have developed AEquity, a tool of identification that reduces biases in datasets used to train machine learning algorithms.

    Oct 24, 2025
  • MyHeritage Adopts Whole Genome Sequencing for Their DNA Tests

    Diagnostics World | Earlier this month, MyHeritage announced that they have upgraded their at-home DNA tests to have Whole Genome Sequencing. By utilizing Ultima Genomics’ sequencing technology and processing at the Gene by Gene lab, MyHeritage is the first major commercial DNA testing company to adopt Whole Genome Sequencing at such a massive scale of over one million tests per year.

    Oct 22, 2025
  • New Glycan-Based Diagnostic May Refine Cancer Detection and Treatment

    Diagnostics World | A new diagnostic tool could soon help oncologists identify which tumors are most vulnerable to a class of immunotherapies that target cancer’s sugar-coated surface. Researchers at the UC Irvine School of Medicine have developed a companion diagnostic that measures glycan density in tumor tissue, which could redefine how solid tumors are detected, classified, and treated.

    Oct 16, 2025
  • GPT Model Could Serve as ‘Early Warning System’ of Disease Risk

    Diagnostics World | An innovative GPT model trained on vast amounts of anonymized data from healthy volunteers in the UK Biobank has been shown to be impressively good at predicting an individual’s risk of developing over 1,200 diseases over the next decade. Since the model represents disease risks as rates, it can also quantify how quickly new cases occur within a population over time.

    Oct 15, 2025
  • A Look at Early Rheumatoid Arthritis Paves New Paths Forward

    Diagnostics World | As people with rheumatoid arthritis (RA) well know, it is a “forever disease” with no single magic-bullet cure or guarantee that they will ever feel like they did before their diagnosis. But a better understanding of what’s happening biologically before the first swollen joint appears could reveal opportunities to markedly modify the course of RA and, ultimately, prevent it.

    Oct 14, 2025
  • AI-powered Digital Pathology Workflows Support Confident Cancer Diagnosis

    Diagnostics World | There are more cases of cancer in the U.S. than ever before. Over 2 million new cases are expected to be diagnosed in 2025 alone, and cancer incidence is on the rise in 6 of the 10 most common cancers. Delivering speedy, accurate diagnoses and treatment for a growing pool of cancer patients is a daunting challenge for today’s clinicians.

    Oct 10, 2025
  • Beyond the Brain Scan: How Emerging Blood Tests Could Change the Way Neurodegenerative Diseases are Detected and Diagnosed Down the Road

    Diagnostics World | We have entered a new era of science focused on developing tools and technologies to support early detection and diagnosis. The rapid evolution of research has led to the need to systematically collect, review, and distill findings into clear and actionable recommendations for how to use these tools in clinical practice

    Oct 1, 2025
  • ‘Super-Simple’ NLP Model Labels Origin of Metastatic Cancer

    Diagnostics World | For patients with metastatic brain cancer, stereotactic radiosurgery has become an increasingly common treatment over the past decade based on the recommendations of medical physicists, guidelines of professional societies, and coverage guidelines of federal agencies. There has also been a change in the drugs used to treat the underlying cancer in conjunction with the procedure, especially in cases of metastatic cancer.

    Sep 30, 2025
  • GE Healthcare Acquires icometrix, Beckman Coulter Launches First Fully Automated BD-Tau Immunoassay Test, More

    Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.

    Sep 25, 2025
  • Follow the Money: Blood-Based Ovarian Cancer Test, Esophageal Diagnostic Platform, More

    Diagnostics World | Mercy BioAnalytics will commercialize their blood-based ovarian cancer test portfolio; Cyted Health will accelerate the commercial expansion of their diagnostics platform in the U.S.; and more.

    Sep 24, 2025
  • Apple Watch Receives FDA Clearance for Hypertension Notifications

    Diagnostics World | Last week Apple introduced Apple Watch Series 11, offering the most comprehensive set of health features yet, longer battery life, an even more durable cover glass, and 5G cellular capabilities, all in its thinnest and most comfortable design. Among the new features, Apple Watch Series 11 introduced FDA-cleared hypertension notifications, which can alert users if signs of chronic high blood pressure — or hypertension — are detected.

    Sep 18, 2025
  • Biomarker Combo Could Guide Treatment of Recurring Ovarian Cancer

    Diagnostics World | Ovarian cancer relapse is a remarkably diverse and dynamic immunological event that when mapped in conjunction with the genomic characteristic of tumors can provide actionable insights about how to enhance the effectiveness of chemotherapy in extending remission and prolonging survival. That’s the promising possibility suggested by researchers in the field who have newly defined four immunologic subtypes of recurrent ovarian cancers.

    Sep 17, 2025
  • AI-Stethoscope Increases Cardiac Condition Diagnoses in Routine Care

    Diagnostics World | Results from one of the largest randomized evaluations of AI in routine care showed that an AI-enabled digital stethoscope significantly increased the number of major cardiac conditions detected compared to the standard of care. The study was led by Imperial College London and Imperial College Healthcare NHS Trust and the results were presented last week at the European Society of Cardiology Congress in Madrid.

    Sep 16, 2025
  • Qure.ai Scans Routine Chest X-Rays for Early Cancer Diagnoses

    Diagnostics World | A clinical case study from Qure.ai and Hacettepe University, Turkey, delivered at the IASLC World Conference on Lung Cancer 2025 in Barcelona, shows that Artificial Intelligence (AI) can detect potentially malignant pulmonary nodules on routine chest X-rays, even when the imaging was ordered for unrelated, non-respiratory conditions.

    Sep 11, 2025
  • Decoding Immune Cell Dialogue to Predict Immunotherapy Responses

    Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue.

    Sep 9, 2025
  • The Great Debate Over AI’s Role in the Microbiology Lab

    Diagnostics World | In a lively matchup between clinical microbiology experts at the recent Next-Generation Dx Summit, onlookers already predisposed to believing artificial intelligence (AI) would not be replacing conventional microbiology and infectious disease testing in the next 10 years were further swayed toward dismissing the possibility. It perhaps helped that the deciding vote on the debate came immediately after the person arguing mightily about the inevitability of an AI takeover himself switched from the affirmative to the negative position.

    Sep 4, 2025
  • Point-of-Care Testing Finding Its Way in Clinical Care

    Diagnostics World | An assortment of “hot-button issues” in point-of-care testing (POCT) remain to be sorted out amid rising patient demand for access to rapid and reliable tests results, mounting financial pressures on healthcare systems, and ongoing concerns about the setting and timing of testing to reap the most clinical benefits. Having actionable results, improving connections to care, and balancing patient anonymity with public health reporting in sexually transmitted infection (STI) testing are among the current topics of dialogue, as highlighted during the Next-Generation Dx Summit held last month.

    Sep 3, 2025
  • Pacific Biosciences Develops Family-Based Genomics Benchmark to Sharpen Diagnostic Accuracy

    Diagnostics World | When it comes to disease diagnostics, every missed genetic variant represents a delay in diagnosis—and often in treatment. Researchers at Pacific Biosciences (PacBio) developed a new genomic benchmark that could help close those diagnostic gaps, offering more accurate detection of genetic variants.

    Sep 2, 2025